Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Pulmonary Disease, Chronic Obstructive × Cyclosporine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Chronic-Phase 3 Leukemia, Myeloid, Accelerated Phase 3 Leukemia 3 Graft vs Host Disease 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Myelodysplastic Syndromes 2 Lymphoma 2 Leukemia, Myeloid, Acute 2 Congenital Abnormalities 2 Anemia, Refractory, with Excess of Blasts 2 Anemia, Refractory 2 Thymic aplasia 1 Skin Neoplasms 1 Pulmonary Disease, Chronic Obstructive 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Biphenotypic, Acute 1 Immunologic Deficiency Syndromes 1 Hodgkin Disease 1 Healthy 1 Burkitt Lymphoma 1

Interventions

Drug Delivery Systems 1 Cyclosporine 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06892756 2025-09-09

DDI2

Chiesi Farmaceutici S.p.A.

Phase 1 Completed

Pulmonary Disease, Chronic Obstructive

Data powered by HemOnc (CC BY 4.0) Colophon ⚡